© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
May 20, 2021
A large retrospective analysis of Medicare patients offers a glimpse of the incidence rates of this patient population and the burdens associated with it.
A meta-analysis suggest the 2 first-line C diff therapies provide similar outcomes, yet differ in recurrent infection risk.
May 02, 2021
Cancer patients are more than twice as likely to acquire hospital-associated Staphylococcus aureus bacteraemia (HA-SAB) and Clostridioides difficile infection (HA-CDI) than others, a new study from Australia found.
April 28, 2021
The proportion of cases with CDI in perforated appendicitis was found to be greater in comparison to the non-perforated cases.
April 26, 2021
Treatment with rifampin shows it can increase the chances for recurrent Clostridium difficile (C diff) infection according to investigators in Mexico.
April 25, 2021
The discovery of C diff’s ability to harness heme to shield itself from the body’s immune responses hopefully brings a new dimension to the fight against the damaging pathogen.
April 24, 2021
CDI prevalence among those hospitalized with a COVID-19 infection was not found to be increased despite more use of antibiotics.
April 23, 2021
Experts discuss the bacteria’s transmission in the community setting, how to reduce disease and economic burdens, and ways to improve quality of life for patients.
April 22, 2021
A study of more than 400 hospitals offers takeaways for creating antibiotic stewardship programs in hospitals around the country.
April 18, 2021
With labs blinding a specific panel, a C diff diagnosis can be masked and missed.